News | May 30, 2025
Procter & Gamble Hygiene and Health Care posts Q3 FY25 PAT at Rs. 156 Cr
The company also announced results for the third quarter, reporting sales at Rs. 992 crore, flat versus year ago
The company also announced results for the third quarter, reporting sales at Rs. 992 crore, flat versus year ago
IGI recently completed the dose-escalation portion of its Phase 1 clinical study in patients with heavily pretreated multiple myeloma
The transaction enhances Roquette’s ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
Bayer expects 2025 to be the most difficult year of its turnaround
A new weapon in the global fight against malaria
The discontinuation decision is only on the basis of commercial reasons and is not due to efficacy or safety reasons
Jobevne is a vascular endothelial growth factor (VEGF) inhibitor that binds with VEGF and blocks the interaction with its receptors to prevent angiogenesis
Asahi Kasei Life Science covers a broad range of bioprocess products and services
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
Subscribe To Our Newsletter & Stay Updated
